MarketCap
Praxis Precision Medicines PRAX
$ 267.68
6.11%
Facebook
X
Telegram
Praxis Precision Medicines Depreciation & Amortization | PRAX
Annual Depreciation & Amortization Praxis Precision Medicines
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 140 K | 358 K | 432 K | 419 K | 182 K | 50 K | 37 K | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 432 K | 37 K | 231 K |
Quarterly Depreciation & Amortization Praxis Precision Medicines
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72 K | 39 K | - | - | 47 K | - | - | - | 112 K | - | - | - | 106 K | - | 314 K | 212 K | 93 K | - | 89 K | 50 K | 23 K | - | 30 K | 20 K | 10 K | - | 27 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 314 K | 10 K | 82.9 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Adverum Biotechnologies
ADVM
|
3.65 M | - | - | $ 86.2 M |  USA |
 |
Unity Biotechnology
UBX
|
867 K | - | -33.41 % | $ 3.37 M | USA |
 |
PainReform Ltd.
PRFX
|
15 K | $ 0.74 | 0.07 % | $ 480 K |  Israel |
 |
Prelude Therapeutics Incorporated
PRLD
|
1.71 M | $ 3.69 | 1.65 % | $ 284 M | USA |
 |
iTeos Therapeutics
ITOS
|
1.24 M | - | - | $ 411 M | USA |
 |
Prothena Corporation plc
PRTA
|
895 K | $ 8.38 | 2.2 % | $ 451 M | USA |
 |
PTC Therapeutics
PTCT
|
38.8 M | $ 61.04 | 0.74 % | $ 4.85 B | USA |
 |
Protagonist Therapeutics
PTGX
|
1.28 M | $ 140.24 | 1.31 % | $ 8.92 B | USA |
 |
Pulmatrix
PULM
|
106 K | $ 1.44 | -2.7 % | $ 5.26 B | USA |
 |
Seelos Therapeutics
SEEL
|
41 K | - | -47.76 % | $ 6.27 M | USA |
 |
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | USA |
 |
Atossa Therapeutics
ATOS
|
16 K | $ 2.45 | -5.91 % | $ 21.1 M | USA |
 |
Ultragenyx Pharmaceutical
RARE
|
35 M | $ 16.09 | 2.78 % | $ 1.59 B | USA |
 |
Arcus Biosciences
RCUS
|
10 M | $ 17.7 | -4.53 % | $ 1.9 B | USA |
 |
Regeneron Pharmaceuticals
REGN
|
544 M | $ 808.08 | 0.38 % | $ 84.5 B | USA |
 |
Replimune Group
REPL
|
3.33 M | $ 12.48 | 8.9 % | $ 1.16 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
83 K | $ 4.63 | 21.05 % | $ 20 M | Israel |
 |
Rafael Holdings
RFL
|
288 K | $ 1.18 | -9.92 % | $ 34.7 M | USA |
 |
REGENXBIO
RGNX
|
15.6 M | $ 6.58 | -1.5 % | $ 339 M | USA |
 |
Kiromic BioPharma
KRBP
|
2.23 M | - | 6.61 % | $ 3.08 M | USA |
 |
Rigel Pharmaceuticals
RIGL
|
2.42 M | $ 49.95 | 3.78 % | $ 898 M | USA |
 |
Compugen Ltd.
CGEN
|
475 K | $ 1.89 | -2.84 % | $ 177 M | Israel |
 |
Relay Therapeutics
RLAY
|
3.56 M | $ 18.16 | -0.11 % | $ 3.12 B | USA |
 |
Coherus BioSciences
CHRS
|
1.3 M | $ 1.0 | -0.5 % | $ 117 M | USA |
 |
Calithera Biosciences
CALA
|
300 K | - | -10.95 % | $ 876 K | USA |
 |
Royalty Pharma plc
RPRX
|
3.85 M | $ 64.76 | 1.4 % | $ 27.8 B | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
500 K | $ 89.56 | 0.32 % | $ 5.82 B | USA |
 |
Rezolute
RZLT
|
31 K | $ 3.82 | -1.04 % | $ 397 M | USA |
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | USA |
 |
Aprea Therapeutics
APRE
|
21.7 K | $ 0.43 | -16.94 % | $ 2.81 M | USA |
 |
Sana Biotechnology
SANA
|
12.8 M | $ 2.36 | 1.29 % | $ 598 M | USA |
 |
Molecular Templates
MTEM
|
6.64 M | - | -23.43 % | $ 495 K | USA |
 |
PDS Biotechnology Corporation
PDSB
|
21.8 K | $ 1.07 | -4.05 % | $ 49.6 M | USA |
 |
BioXcel Therapeutics
BTAI
|
300 K | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
Seer
SEER
|
5.12 M | $ 1.93 | -2.03 % | $ 107 M | USA |
 |
CohBar
CWBR
|
99.2 K | - | -15.44 % | $ 2.2 M | USA |
 |
SIGA Technologies
SIGA
|
563 K | $ 3.16 | 1.12 % | $ 226 M | USA |
 |
NeuBase Therapeutics
NBSE
|
800 K | - | -1.56 % | $ 12.3 M | USA |
 |
Olema Pharmaceuticals
OLMA
|
490 K | $ 6.61 | 3.04 % | $ 575 M | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
109 K | $ 70.54 | 1.57 % | $ 197 M | Israel |
 |
Deciphera Pharmaceuticals
DCPH
|
2.1 M | - | - | $ 2.18 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
3.87 M | - | -6.81 % | $ 3.04 B | USA |
 |
Scopus BioPharma
SCPS
|
1.73 K | - | -48.37 % | $ 3.71 M | USA |
 |
Syndax Pharmaceuticals
SNDX
|
6 M | $ 13.21 | -1.42 % | $ 1.14 B | USA |
 |
Soligenix
SNGX
|
62.4 K | $ 0.35 | -4.08 % | $ 1.82 M | USA |
 |
scPharmaceuticals
SCPH
|
20 K | - | - | $ 218 M | USA |